19.01.2013 Views

Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...

Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...

Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Natuurkundige <strong>voor</strong>drachten I Nieuwe reeks 89<br />

Migraine: de ontrafeling van een complexe ziekte<br />

112<br />

sias) and negative (e.g., scotomata, paresis) phe-<br />

<strong>no</strong>mena of the migraine aura can be well explained<br />

by the biphasic nature of CSD, in which the neuronal<br />

depression is frequently preceded by transient<br />

hyperexcitability. Most importantly however, functional<br />

neuroimaging studies have demonstrated<br />

that the changes in CBF during a migraine aura are<br />

highly reminiscent of those observed in experimental<br />

animals during CSD. Using functional MRI,<br />

Hadjikhani and colleagues found a focal increase in<br />

the blood oxygen level-dependent (BOLD) signal that<br />

spread through the occipital cortex at a rate of 3.5<br />

mm/min. The direction and speed of the spread were<br />

in agreement with the visual experiences reported by<br />

the patient, and the increased BOLD signal was followed<br />

by a decrease in signal. This pattern would be<br />

consistent with a brief initial rise in CBF followed by a<br />

longer-lasting decrease in blood flow.<br />

C. CSD as the trigger of the headache phase<br />

Despite mounting evidence that CSD underlies<br />

the migraine aura, it remains unclear whether CSD<br />

may trigger the headache phase itself, perhaps via<br />

activation of the trigemi<strong>no</strong>vascular system. Animal<br />

experiments have provided evidence in support<br />

of this hypothesis. For example, high K + -induced<br />

CSD in the rat parietal cortex can activate ipsilateral<br />

trigeminal nucleus caudalis neurons and cause<br />

long-lasting elevated blood flow in the middle<br />

meningeal artery, as well as dural plasma protein<br />

leakage that can be inhibited by ipsilateral trigeminal<br />

nerve resection. Moreover, treatment with several<br />

classes of migraine prophylactic drugs inhibits<br />

experimentally induced CSDs as measured with<br />

electrophysiology and cerebral blood flow. In contrast<br />

to animal studies, the connection between<br />

CSD and the headache phase in patients remains an<br />

open question. Goadsby reviewed the mainly clinical<br />

arguments against the hypothesis that CSD may<br />

also trigger headache mechanisms. First, only one<br />

third of migraineurs report having auras, raising the<br />

question of how the headache phase is triggered in<br />

patients without aura. One possible explanation is<br />

that all migraineurs might indeed have SD, but that<br />

perhaps MO patients exhibit (C)SD in clinically silent<br />

subcortical areas of the brain without propagating<br />

to the visual cortex. Although formally possible,<br />

this hypothesis is difficult to test directly; however,<br />

one case reported spreading cerebral hypoperfusion<br />

during the headache phase in an MO patient.<br />

Second, the aura and the headache phase would<br />

be predicted to occur on opposite sides if CSD activates<br />

the trigemi<strong>no</strong>vascular system, but in some<br />

cases the headache can occur on the same side as<br />

the aura. Third, in some cases aura can occur after<br />

the headache has started, suggesting that it might<br />

<strong>no</strong>t serve to trigger the headache. Fourth, aura is<br />

<strong>no</strong>t unique to migraineurs. For example, auras have<br />

been reported with attacks of cluster headache, paroxysmal<br />

hemicrania and hemicrania continua.<br />

Finally, treatment with intranasal ketamine has<br />

been reported to abort migraine aura but failed to<br />

prevent the headache phase. Yet despite these arguments,<br />

the exact role, if any, that spreading depression<br />

plays in triggering migraine headache mechanisms<br />

remains unclear and the subject of intense<br />

investigation.<br />

IV. MIGRAINE AS A GENETIC DISORDER<br />

A. Genetic epidemiology of migraine<br />

There is considerable evidence to support the <strong>no</strong>tion<br />

that migraine has an underlying genetic basis. First,<br />

migraine frequently runs in families, and population-based<br />

studies have confirmed that the risk of<br />

migraine in first-degree relatives is 1.5- to 4-fold<br />

greater than in <strong>no</strong>nrelated individuals. This familial<br />

risk is highest for MA patients, with a young age of<br />

onset and a high attack severity and disease disability.<br />

Using the basis of differing estimates of heritability,<br />

some reports have suggested that MA and MO<br />

are different entities. However, several arguments<br />

suggest instead that the aura component may have<br />

some heritable biological distinction. For example,<br />

many migraineurs experience both MA and MO<br />

attacks throughout their lifetime, for example, MA<br />

in childhood, MO in young adulthood, and MA again<br />

in later life. Furthermore, an Australian study of<br />

more than 6000 twin pairs used the basis of the patterns<br />

and severity of migraine symptoms to identify<br />

disease subtypes (‘latent classes’), arguing against

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!